Exploring Neuroprotective Agents for Sepsis-Associated Encephalopathy: A Comprehensive Review.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
28 Jun 2023
Historique:
received: 30 05 2023
revised: 20 06 2023
accepted: 26 06 2023
medline: 17 7 2023
pubmed: 14 7 2023
entrez: 14 7 2023
Statut: epublish

Résumé

Sepsis is a life-threatening condition resulting from an inflammatory overreaction that is induced by an infectious factor, which leads to multi-organ failure. Sepsis-associated encephalopathy (SAE) is a common complication of sepsis that can lead to acute cognitive and consciousness disorders, and no strict diagnostic criteria have been created for the complication thus far. The etiopathology of SAE is not fully understood, but plausible mechanisms include neuroinflammation, blood-brain barrier disruption, altered cerebral microcirculation, alterations in neurotransmission, changes in calcium homeostasis, and oxidative stress. SAE may also lead to long-term consequences such as dementia and post-traumatic stress disorder. This review aims to provide a comprehensive summary of substances with neuroprotective properties that have the potential to offer neuroprotection in the treatment of SAE. An extensive literature search was conducted, extracting 71 articles that cover a range of substances, including plant-derived drugs, peptides, monoclonal antibodies, and other commonly used drugs. This review may provide valuable insights for clinicians and researchers working in the field of sepsis and SAE and contribute to the development of new treatment options for this challenging condition.

Identifiants

pubmed: 37445958
pii: ijms241310780
doi: 10.3390/ijms241310780
pmc: PMC10342126
pii:
doi:

Substances chimiques

Neuroprotective Agents 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

JAMA. 2016 Feb 23;315(8):801-10
pubmed: 26903338
Neurotox Res. 2020 Dec;38(4):871-886
pubmed: 32524380
Behav Brain Res. 2015;287:59-72
pubmed: 25794930
Mol Med Rep. 2021 Feb;23(2):
pubmed: 33355378
Animal Model Exp Med. 2021 May 03;4(3):249-260
pubmed: 34557651
Biomol Concepts. 2014 Jun;5(3):195-208
pubmed: 25372753
Clin Nutr. 2019 Oct;38(5):2053-2064
pubmed: 30266270
Lancet Respir Med. 2015 Jan;3(1):61-9
pubmed: 25434614
Brain Behav Immun. 2017 Feb;60:293-303
pubmed: 27833044
Exp Neurol. 2023 Jan;359:114263
pubmed: 36336029
JAMA. 2017 Apr 4;317(13):1321-1328
pubmed: 28322414
Intensive Care Med. 2020 Aug;46(8):1552-1562
pubmed: 32572531
Front Nutr. 2021 Jul 13;8:701760
pubmed: 34327209
Expert Rev Anti Infect Ther. 2021 Feb;19(2):215-231
pubmed: 32808580
J Gerontol A Biol Sci Med Sci. 2021 Jan 1;76(1):32-40
pubmed: 32300799
Neurol India. 2018 Mar-Apr;66(2):352-361
pubmed: 29547154
mSystems. 2022 Jun 28;7(3):e0139921
pubmed: 35642838
Langenbecks Arch Surg. 1998 Mar;383(1):44-8
pubmed: 9627170
J Intensive Care. 2020 Jul 02;8:45
pubmed: 32637121
J Surg Res. 2017 Jan;207:181-189
pubmed: 27979475
Brain Res. 2018 Nov 1;1698:54-61
pubmed: 29932894
Brain Res Bull. 2020 Jun;159:53-60
pubmed: 32272155
Front Neurol. 2022 Sep 29;13:999035
pubmed: 36247756
J Inflamm Res. 2022 Mar 30;15:2103-2119
pubmed: 35386224
Mol Cell Biochem. 2014 Jan;385(1-2):125-32
pubmed: 24057122
Ann Transl Med. 2021 Dec;9(24):1802
pubmed: 35071496
Neurotox Res. 2021 Apr;39(2):119-132
pubmed: 33025358
J Clin Med. 2020 Mar 05;9(3):
pubmed: 32150970
Can J Neurol Sci. 2018 Nov;45(6):688-691
pubmed: 30430963
Crit Care Med. 2014 Jan;42(1):e12-21
pubmed: 24145836
Crit Care Med. 2014 Aug;42(8):1899-909
pubmed: 24810528
J Surg Res. 2013 Jul;183(1):304-12
pubmed: 23236988
Cell J. 2020 Jul;22(Suppl 1):29-37
pubmed: 32779431
J Mol Neurosci. 2020 Dec;70(12):2049-2057
pubmed: 32468218
Int Immunopharmacol. 2023 Jan;114:109603
pubmed: 36538853
Biochem Biophys Res Commun. 2019 Sep 17;517(2):221-226
pubmed: 31331643
Drug Des Devel Ther. 2019 Oct 03;13:3465-3475
pubmed: 31631971
Int Immunopharmacol. 2021 Jun;95:107583
pubmed: 33773206
Respir Res. 2021 May 13;22(1):149
pubmed: 33985501
J Matern Fetal Neonatal Med. 2012 Oct;25 Suppl 3:11-4
pubmed: 23016611
Crit Care Med. 2021 Nov 1;49(11):1974-1982
pubmed: 34643578
Life Sci. 2019 Sep 1;232:116647
pubmed: 31301416
Shock. 2017 Aug;48(2):209-214
pubmed: 28187038
Brain Res Brain Res Rev. 2000 Sep;33(2-3):228-41
pubmed: 11011067
Adv Med. 2014;2014:762320
pubmed: 26556425
J Int Med Res. 2018 Jul;46(7):2828-2842
pubmed: 29756489
Toxicol Appl Pharmacol. 2019 Jan 15;363:34-46
pubmed: 30336174
Front Immunol. 2016 Feb 01;7:28
pubmed: 26870043
Shock. 2021 Jan 1;55(1):100-109
pubmed: 32590694
Intensive Care Med. 2020 Aug;46(8):1536-1551
pubmed: 32591853
Brain Behav Immun. 2021 Jan;91:296-314
pubmed: 33039659
Int Immunopharmacol. 2020 Aug;85:106585
pubmed: 32447221
Curr Neurovasc Res. 2022;19(1):38-46
pubmed: 35430992
Rom J Intern Med. 2020 Sep 1;58(3):129-137
pubmed: 32396142
J Interferon Cytokine Res. 2022 Jun;42(6):267-278
pubmed: 35420462
Cell Mol Neurobiol. 2017 Oct;37(7):1195-1205
pubmed: 27904994
Mol Med Rep. 2019 Nov;20(5):4731-4740
pubmed: 31702043
J Immunol Res. 2022 Sep 13;2022:3334145
pubmed: 36148090
Neurol Res. 2017 Apr;39(4):357-366
pubmed: 28173746
CNS Neurosci Ther. 2022 Feb;28(2):247-258
pubmed: 34837343
Physiol Rev. 2019 Oct 1;99(4):1877-2013
pubmed: 31460832
J Mol Neurosci. 2017 Sep;63(1):1-8
pubmed: 28601977
Oxid Med Cell Longev. 2021 Feb 15;2021:6647258
pubmed: 33628372
Front Immunol. 2021 Jan 28;12:626894
pubmed: 33584734
Neurocrit Care. 2010 Feb;12(1):35-42
pubmed: 19806473
Inflamm Res. 2020 Jul;69(7):697-710
pubmed: 32350570
Mol Neurobiol. 2021 Jun;58(6):2770-2779
pubmed: 33495934
Crit Care Med. 2015 Jun;43(6):1213-22
pubmed: 25760659
Neurochem Res. 2013 Nov;38(11):2440-9
pubmed: 24072674
J Neurol Neurosurg Psychiatry. 2013 Jan;84(1):62-9
pubmed: 23134661
Crit Care. 2010;14(4):R140
pubmed: 20667108
JAMA. 2007 Dec 12;298(22):2644-53
pubmed: 18073360
J Cell Mol Med. 2022 Nov;26(22):5713-5727
pubmed: 36308410
CNS Neurosci Ther. 2023 Feb;29(2):633-645
pubmed: 36468415
Int Immunopharmacol. 2020 Apr;81:106287
pubmed: 32058932
J Transl Med. 2022 Nov 26;20(1):546
pubmed: 36435787
J Agric Food Chem. 2020 Dec 16;68(50):14874-14883
pubmed: 33284020
Cell Mol Neurobiol. 2020 May;40(4):521-530
pubmed: 31696375
J Surg Res. 2015 Apr;194(2):591-598
pubmed: 25534234
Front Neurol. 2022 Jun 10;13:909436
pubmed: 35756942
World J Emerg Med. 2022;13(5):367-372
pubmed: 36119770
Oxid Med Cell Longev. 2020 Nov 30;2020:2638130
pubmed: 33312335
Neuroscience. 2021 Jul 1;466:87-100
pubmed: 33992722
Neurotox Res. 2022 Feb;40(1):267-275
pubmed: 34981455
Nat Med. 2007 Jun;13(6):688-94
pubmed: 17486089
Neurosci Lett. 2016 Sep 19;631:70-78
pubmed: 27400829
Shock. 2021 Nov 1;56(5):824-831
pubmed: 33595259
Nat Rev Neurol. 2012 Oct;8(10):557-66
pubmed: 22986430

Auteurs

Klaudia Krzyzaniak (K)

Department of Emergency Medicine, Medical University of Gdansk, Smoluchowskiego 17, 80-214 Gdansk, Poland.

Robert Krion (R)

Department of Emergency Medicine, Medical University of Gdansk, Smoluchowskiego 17, 80-214 Gdansk, Poland.

Aleksandra Szymczyk (A)

Department of Emergency Medicine, Medical University of Gdansk, Smoluchowskiego 17, 80-214 Gdansk, Poland.

Ewelina Stepniewska (E)

Department of Emergency Medicine, Medical University of Gdansk, Smoluchowskiego 17, 80-214 Gdansk, Poland.

Mariusz Sieminski (M)

Department of Emergency Medicine, Medical University of Gdansk, Smoluchowskiego 17, 80-214 Gdansk, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH